Gene · 288
Papers1,871
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,871
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reframing the axon initial segment: Giant ankyrin-G as a modulator of excitability and plasticity in neurodevelopment. | Proc Natl Acad Sci U S A | 2026 | 41499407 | PubTator, text mining | PubMed |
| Imaging transcriptomics identifies gene signatures associated with cortical thinning in schizophrenia. | J Psychiatr Res | 2026 | 41494489 | PubTator, text mining | PubMed |
| Can We Develop Glioma Subtype-Specific Precision Medicines? An Integrative Machine Learning Pipeline for Biomarker Discovery and Drug Repurposing for Glioblastoma and Low-Grade Glioma. | OMICS | 2026 | 41468121 | PubTator, text mining | PubMed |
| Restricting Liafensine on the Basis of ANK3 Genotype-More Evidence Needed. | JAMA Psychiatry | 2026 | 41433028 | PubTator, text mining | PubMed |
| Restricting Liafensine on the Basis of ANK3 Genotype-More Evidence Needed-Reply. | JAMA Psychiatry | 2026 | 41433025 | PubTator, text mining | PubMed |
| A functional role for Septin-2 in the maintenance of the axon initial segment and in human cognitive development. | Brain | 2026 | 41408595 | PubTator, text mining | PubMed |
| A neuron type-specific microexon in Ank3/ankyrin-G modulates calcium activity and neuronal excitability. | bioRxiv | 2025 | 41427402 | PubTator, text mining | PubMed |
| Multi-scale cancer driver gene prediction by flexible data selection and network topology guidance. | J Biomed Inform | 2025 | 41276241 | PubTator, text mining | PubMed |
| ANK3 Is Regulated by Recursive Splicing and Inhibits Hepatocellular Carcinoma Metastasis by Inhibiting E-Cadherin Protein Degradation. | Front Biosci (Landmark Ed) | 2025 | 41198552 | PubTator, text mining | PubMed |
| Downregulation of ankyrin 3 (ANK3) promotes malignant behaviors associated with altered adhesion dynamics and actin cytoskeleton remodeling in renal cell carcinoma. | Cell Tissue Res | 2025 | 41186628 | PubTator, text mining | PubMed |
| Pan-Cancer Landscape of Magnesium Homeostasis: Bulk Omics Research and Single-Cell Sequencing Validation. | Biol Proced Online | 2025 | 41174507 | PubTator, text mining | PubMed |
| A Pilot Epigenome-Wide Study of Posttraumatic Growth: Identifying Novel Candidates for Future Research. | Epigenomes | 2025 | 41133714 | PubTator, text mining | PubMed |
| Consciousness and spintronic coherence in microtubules. | Commun Integr Biol | 2025 | 41132902 | PubTator, text mining | PubMed |
| Integrative RNA-seq and LASSO-COX analysis reveal Paeonol's key target gene in proliferation suppression and apoptosis-induced in cervical cancer. | Front Pharmacol | 2025 | 41126956 | PubTator, text mining | PubMed |
| SPP1high macrophage-induced T-cell stress promotes colon cancer liver metastasis through SPP1/CD44/PI3K/AKT signaling. | J Immunother Cancer | 2025 | 41120125 | PubTator, text mining | PubMed |
| Effect of stretch on conduction in myelinated nerve due to wrist movement: An experimental and analytical study. | PLoS One | 2025 | 41071796 | PubTator, text mining | PubMed |
| Paraneoplastic Brachial Amyotrophic Diplegia With Favorable Outcome and Anti-Ank3 Antibodies: A Case Report. | Neurol Neuroimmunol Neuroinflamm | 2025 | 41052378 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective. | Cancer Rep (Hoboken) | 2025 | 40948427 | PubTator, text mining | PubMed |
| Identification of a 13-Gene Immune Signature in Liver Fibrosis Reveals GABRE as a Novel Candidate Biomarker. | Int J Mol Sci | 2025 | 40943308 | PubTator, text mining | PubMed |
| ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression: The ENLIGHTEN Randomized Clinical Trial. | JAMA Psychiatry | 2025 | 40928787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/288/papers?page=2